D. Hills

Abstract P4-01-02: The role of FLT PET early assessment of response to endocrine therapy for early stage breast cancer

D. Mankoff, H. Linden, J. Eary, 2013 .

Specific targeting of a mutant, activated egf receptor found in glioblastoma using a monoclonal antibody

W. Gullick, G. Rowlinson-Busza, D. Hills, 1995, International journal of cancer.

Expression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to an EGF‐receptor‐specific antibody‐toxin

W. Wels, W. Gullick, Mathias Schmidt, 1998 .

Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study.

H. Hochster, F. Muggia, P. Ivy, 2008, Gynecologic oncology.

Expression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to an EGF-receptor-specific antibody-toxin.

W. Wels, W. Gullick, M. Schmidt, 1998, International journal of cancer.